[Role of Cripto-1 protein in development and target therapy of breast cancer].
Lei
Ting
T
Guo
Xiao-jing
XJ
Fu
Li
L
D000818:Animals; D000911:Antibodies, Monoclonal / Q000378:metabolism / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D016503:Drug Delivery Systems; D004815:Epidermal Growth Factor / Q000276:immunology / Q000378:metabolism / Q000502:physiology; D058750:Epithelial-Mesenchymal Transition; D058851:GPI-Linked Proteins; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D036341:Intercellular Signaling Peptides and Proteins; D008562:Membrane Glycoproteins / Q000276:immunology / Q000378:metabolism / Q000502:physiology; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000276:immunology / Q000378:metabolism / Q000502:physiology
D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor; D058851:GPI-Linked Proteins; D036341:Intercellular Signaling Peptides and Proteins; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; C070636:TDGF1 protein, human; D004815:Epidermal Growth Factor